Docetaxel trials for NSCLC (Advanced Non-small Cell Lung Cancer)

All Docetaxel trials · All NSCLC (Advanced Non-small Cell Lung Cancer) trials

Phase breakdown

Recruiting trials studying Docetaxel for NSCLC (Advanced Non-small Cell Lung Cancer)

• Microwave Ablation Plus Tislelizumab and Docetaxel in Advanced NSCLC After First-Line Immunotherapy Failure
  NCT07528274 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Oral Pooled Fecal Microbiotherapy (MaaT033) Concomitant to Cemiplimab Versus Best Investigator's Choice in Patients With Resistance to Treatment Due to Antibiotics Uptake With Advanced Non-small Cell Lung Cancer
  NCT07001618 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 6 locations
• Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)
  NCT06881784 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 153 locations

Common questions

How many trials study Docetaxel for NSCLC (Advanced Non-small Cell Lung Cancer)?

3 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.